Meiji Indonesian Pharmaceutical Industries is a finished-dose manufacturer based in Indonesia. It appears in 76 regulatory filings across 1 regulator, without an active US DMF or CEP on file. Customs aggregates show $3.9M of exports covering 38 molecules to 1 destination in 2025.
| Site | FDA FEI |
|---|---|
| KAB. PASURUAN, Indonesia | Not on file |
| -, Indonesia | Not on file |
| Regulator | Filings | GMP certificates |
|---|---|---|
| BPOM (ID) | 76 | None |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2025 | Not reported | $3.9M | 1 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.
Choose your molecules and target markets. Meiji Indonesian Pharmaceutical Industries comes back tiered against every other supplier able to file there.
Start for freeRanked by shared active ingredients where we have them, otherwise by country and comparable credentials.